2m 2m 2m 2m 2m 2m 2m
Nymox Pharma (NYMXF)
OTC
$0.09-$0.02 (-18.09%)
Price as of Jun 23, 2026- $18.1MMarket Cap
- 26.01%1-Year Change
- BiotechnologyIndustry
Nymox Pharma (NYMXF)
$0.09-$0.02 (-18.09%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 55
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.09
$0.12
$0.09
1-Year Range
$0.04
$0.15
$0.09
Latest Close$0.09
Change
-$0.02 (-22.09%)
Volume13,633
Market Cap$18.1M
Shares Outstanding90.5M
P/E (TTM)-2.75
Diluted EPS (TTM)-$0.07
Enterprise Value$16.7M
Information as of 06/23/2026
Company Profile
NYMOX PHARM CORP
$18.1M
Market Cap
-$6.6M
Net Income
Sector: Healthcare
Industry: Biotechnology
NYMOX PHARM CORP
Key Executives
- Patrick Doody
- Lin Dodd
- Paul Averback DABP
Current Ownership Distribution
- Other94.5M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)